Patent 11160455

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Active provider: Google · gemini-2.5-flash

Ownership chain (1)

Asserters network →

Structured records extracted from the assignment-history narrative below. Each entity links to its full ownership-network profile.

2020-10-23 · reel 056461/0819 · Assignment
Mohammed N. Islam OMNI MEDSCI, INC.
Correspondent: Jeffrey M. Lilly · Omni Medsci Inc.
Original assignment from inventor to company

Assignment history

✓ Generated

Inventors

Mohammed N. Islam (Employer: Omni Medsci Inc at time of filing)

Original assignee

Omni Medsci Inc. It is unclear from the patent text or general knowledge whether Omni Medsci Inc. has shipped a product embodying the claims. Their primary line of business, as indicated by the patent, appears to be related to medical devices for non-invasive blood measurements and other diagnostic techniques using multi-wavelength light. Their current status is operating, as they are listed as the current assignee and have active litigation surrounding this patent.

Assignment timeline

2020-10-23 (executed) / recorded 2020-10-23 — Reel 056461/0819
- Conveyance: Assignment
- Assignor: Mohammed N. Islam
- Assignee: Omni Medsci Inc.
- Correspondent: Jeffrey M. Lilly, Omni Medsci Inc., 301 E. Liberty, Suite 400, Ann Arbor, MI 48104
- Context: Original assignment from inventor to company.

Timeline diagram

timeline
    title Ownership of US 11160455
    2020 : Application filed
         : Assigned to Omni Medsci Inc
    2021 : Patent granted
    2024 : US case filed in Texas Eastern District Court
    2025 : PTAB case IPR2025-01252 filed (Instituted)
         : PTAB case IPR2025-01585 filed (Not Instituted)
         : US case filed in Delaware District Court

NPE / troll-pattern signals

Shell-entity transfer — not present. The initial and only assignment recorded is from the inventor to Omni Medsci Inc., which appears to be an operating company based on the detailed technical descriptions in the patent and ongoing litigation.
Known asserter in the chain — not present. Omni Medsci Inc. is not identified as a known NPE on public lists.
Repeat correspondent across the chain — not present. Only one assignment is recorded, so there is no recurrence.
Cascading transfers — not present. Only one assignment is recorded.
Pre-litigation transfer — not present. The assignment to Omni Medsci Inc. was recorded on 2020-10-23 (Reel 056461/0819), while the earliest litigation linked to this patent was filed in 2024 (US case filed in Texas Eastern District Court), well over six months later.
Bankruptcy fire-sale — not present. There is no indication of bankruptcy in the provided information or Google Patents legal events.
Privateering — unclear. While Omni Medsci Inc. is involved in litigation, there is no information to suggest they are asserting patents on behalf of another operating company.
Defensive aggregator (anti-NPE) — not present. The current assignee is Omni Medsci Inc., not a defensive aggregator.

Verdict

Operating-company assertion. The patent was assigned directly from the inventor to Omni Medsci Inc. (Reel 056461/0819), and Omni Medsci Inc. is currently involved in litigation surrounding this patent, indicating active assertion of their intellectual property. There are no clear signals of NPE behavior such as shell entity transfers or known NPE assignees in the chain.

Verification: https://assignmentcenter.uspto.gov/

Generated 5/24/2026, 12:48:25 PM